Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study
Authors
Keywords
Chronic kidney disease, Tryptophan, Kynurenine, Neopterin, Cortisol, Inflammation, Depression, Anxiety, Cognition
Journal
BMC Nephrology
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-10
DOI
10.1186/s12882-016-0387-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials
- (2016) Gerald Schulman et al. BMC Nephrology
- Tubular Secretion in CKD
- (2015) A. M. Suchy-Dicey et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fatigue and plasma tryptophan levels in patients on chronic hemodialysis
- (2015) Maurizio Bossola et al. KIDNEY INTERNATIONAL
- Effects of AST-120 on Blood Concentrations of Protein-Bound Uremic Toxins and Biomarkers of Cardiovascular Risk in Chronic Dialysis Patients
- (2014) Chien-Te Lee et al. BLOOD PURIFICATION
- Associations of Depressive Symptoms and Pain with Dialysis Adherence, Health Resource Utilization, and Mortality in Patients Receiving Chronic Hemodialysis
- (2014) S. D. Weisbord et al. Clinical Journal of the American Society of Nephrology
- Effect of Increasing Dietary Fiber on Plasma Levels of Colon-Derived Solutes in Hemodialysis Patients
- (2014) T. L. Sirich et al. Clinical Journal of the American Society of Nephrology
- Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care
- (2014) Dirk M. Hermann et al. JOURNAL OF NEURAL TRANSMISSION
- Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD
- (2014) G. Schulman et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Altered tryptophan metabolism and CKD-associated fatigue
- (2014) Henricus A.M. Mutsaers et al. KIDNEY INTERNATIONAL
- The Kidney and Uremic Toxin Removal: Glomerulus or Tubule?
- (2014) Rosalinde Masereeuw et al. SEMINARS IN NEPHROLOGY
- The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease
- (2014) Marion Sallée et al. Toxins
- Protein-Bound Uremic Toxins: New Culprits of Cardiovascular Events in Chronic Kidney Disease Patients
- (2014) Shunsuke Ito et al. Toxins
- Kynurenines in CNS disease: regulation by inflammatory cytokines
- (2014) Brian M. Campbell et al. Frontiers in Neuroscience
- The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders
- (2013) Trevor W Stone et al. BRITISH JOURNAL OF PHARMACOLOGY
- Renal Clearance and Intestinal Generation of p-Cresyl Sulfate and Indoxyl Sulfate in CKD
- (2013) R. Poesen et al. Clinical Journal of the American Society of Nephrology
- Serotonin – Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
- (2013) Gregory Oxenkrug CURRENT DRUG TARGETS
- Targeting protein-bound uremic toxins in chronic kidney disease
- (2013) Toshimitsu Niwa EXPERT OPINION ON THERAPEUTIC TARGETS
- Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy
- (2013) Charlotte McKercher et al. NEPHROLOGY
- Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
- (2013) Aye-Mu Myint et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
- (2013) Adrian L. Lopresti et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study
- (2013) Charlotte M McKercher et al. BMC Nephrology
- VANTED v2: a framework for systems biology applications
- (2012) Hendrik Rohn et al. BMC Systems Biology
- Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation
- (2012) Martina M. Hughes et al. BRAIN BEHAVIOR AND IMMUNITY
- Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis
- (2012) Heng-Jung Hsu et al. GENERAL HOSPITAL PSYCHIATRY
- Normal and Pathologic Concentrations of Uremic Toxins
- (2012) F. Duranton et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP)*
- (2012) Evi V. Nagler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients
- (2012) María Jesús Izquierdo et al. BMC Nephrology
- Chronic Low-Grade Inflammation in Elderly Persons Is Associated with Altered Tryptophan and Tyrosine Metabolism: Role in Neuropsychiatric Symptoms
- (2011) Lucile Capuron et al. BIOLOGICAL PSYCHIATRY
- Estimated Glomerular Filtration Rate Is a Poor Predictor of Concentration for a Broad Range of Uremic Toxins
- (2011) S. Eloot et al. Clinical Journal of the American Society of Nephrology
- Enhanced degradation of tryptophan in patients on hemodialysis
- (2011) P. Koenig et al. CLINICAL NEPHROLOGY
- Colonic Contribution to Uremic Solutes
- (2011) P. A. Aronov et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mechanism of acute tryptophan depletion: is it only serotonin?
- (2011) E L van Donkelaar et al. MOLECULAR PSYCHIATRY
- Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST-120
- (2011) Toshimitsu Niwa THERAPEUTIC APHERESIS AND DIALYSIS
- Crystal Structure-Based Selective Targeting of the Pyridoxal 5′-Phosphate Dependent Enzyme Kynurenine Aminotransferase II for Cognitive Enhancement
- (2010) Franca Rossi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metabolite Profiling Identifies Markers of Uremia
- (2010) E. P. Rhee et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
- (2010) M. Maes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inflammation-associated depression: From serotonin to kynurenine
- (2010) Robert Dantzer et al. PSYCHONEUROENDOCRINOLOGY
- Epidemiology, Diagnosis, and Management of Depression in Patients With CKD
- (2009) S. Susan Hedayati et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Uremic toxins originating from colonic microbial metabolism
- (2009) Pieter Evenepoel et al. KIDNEY INTERNATIONAL
- Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms
- (2009) J. C. Schefold et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease
- (2008) Krystyna Pawlak et al. ATHEROSCLEROSIS
- A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression
- (2008) Hideki Miura et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More